LK

Sri Lanka

134 clinical trials

Find Trials

Clinical Trials (134)

Showing 20 of 134 trialsScroll for more
NCT07569640Phase 312 sites

HFrEF Polypill in Sri Lanka RCT

Recruiting

Prospective Study on Antimicrobial RESIstance in Chronic Pulmonary DiseasE

Recruiting

Skin Type Determination Using Image Artificial Intelligence

Recruiting
NCT06058585Phase 39 sites

The Chronic Kidney Disease Adaptive Platform Trial Investigating Various Agents for Therapeutic Effect

Recruiting

Atacicept in Subjects With IgA Nephropathy

Active Not Recruiting

A Combination Triple Pill Implementation Strategy for Blood Pressure cONtrol

Completed
NCT06008197Phase 312 sites

A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients

Recruiting
NCT06024746Phase 35 sites

A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)

Recruiting

Administering Atropine Through Autoinjectors Within Ambulance Services for Poisoning Patients in Sri Lanka's North Central Province

Not Yet Recruiting

EdoxabaN foR IntraCranial Hemorrhage Survivors With Atrial Fibrillation (ENRICH-AF)

Completed
NCT06466135Phase 25 sites

Study of WAL0921 in Patients With Glomerular Kidney Diseases

Recruiting
NCT06331364Not Applicable3 sites

TREATment of Lower Respiratory Tract Infection in Selected Hospitals in Southern Sri Lanka (TREAT-SL): a Stepped-Wedge Cluster Randomized Trial

Recruiting
NCT05248646Phase 35 sites

Trial of Sibeprenlimab in the Treatment of A Nephropathy (IgAN)

Active Not Recruiting
NCT06033950Phase 38 sites

A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists

Recruiting

A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Atacicept

Enrolling By Invitation
NCT05248659Phase 2/34 sites

Trial of Sibeprenlimab in the Treatment of Immunoglobulin A Nephropathy (IgAN)

Enrolling By Invitation
NCT04287985Phase 23 sites

Safety and Efficacy Study of VIS649 for IgA Nephropathy

Completed

ICU-related Out of Pocket Expenses (ICOPE)

Recruiting
NCT07440056Not Applicable1 site

Physical Inactivity Among Patients With Cardiovascular Risk

Not Yet Recruiting
NCT05164263Phase 42 sites

Real World Safety & Efficacy Experience of Empagliflozin With or Without Metformin in T2DM Patients - EASE Study

Recruiting